BBNX vs CVX · rev $100.3M vs P/E 17, rev $118.66B
Beta Bionics, Inc. Common Stock (BBNX) versus Chevron Corp (CVX) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Chevron Corp (CVX) is a oil & gas integrated company listed on US. It is led by Michael K. Wirth.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported CVX revenue for 2026-06-30 was $118.66B. Net income was $14.28B. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
BBNX currently screens at market cap $640.8M. CVX currently screens at market cap $250.20B and trailing P/E 16.5.
Not investment advice. Open the BBNX and CVX stock pages for the full models.
Not investment advice.